JPRN-UMIN000008250已完成未知
Visceral fat and adipocytokine profile in Japanese patients with type2 diabetes mellitus treated with DPP-4 inhibitors. - DPP-4 inhibitors and visceral fat
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
Per test planner retirement
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who were added other OADs during the course of the trial. 2) Patients on corticodteroid. 3) Patients with renal impairment or moderate to severe hepatic dysfunction. 4) Patients with heart failure. 5) Patients treated with insulin or who absolutely needs insulin treatment. 6) Patients with current malignancy. 7) Patients with endocrine disorders. 8) Patients with severe mental illness. 9) Patients with pregnancy or lactating. 10) An excessive alcohol drunker. 11) Patients under the contraindication of each drugs.
研究者
相似试验
已完成
不适用
Japanese Study of Visceral Adiposity and Lifestyle Information; Utilized and Evaluated 2ObesityJPRN-UMIN000006447Kao Corporation300
已完成
不适用
Investigation of the visceral fat and adipocytokine by SGLT2 inhibitors in type 2 diabetes millitustype 2 diabetes mellitusJPRN-UMIN000022561Dokkyo medical university, Endocrinology and Metabolism60
招募中
不适用
Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2Type 2 Diabetes Mellitus (T2DM)Hyperuricemia or GoutHyperuricemia, GoutObesity/EpidemiologyObesity, AbdominalCentral ObesityVisceral FatChronic Kidney Disease(CKD)Metabolic SyndromeHepatic SteatosisInsulin Sensitivity/ResistanceObesityHypertensionType 2 DiabetesDiabetes MellitusAtherosclerosisDyslipidemiaHyperlipidemiaHyperglycemiaNCT06694012Osaka Metropolitan University2,000
已完成
不适用
Benefit study of traditional Japanese diet 2Healthy aduitsJPRN-UMIN000020449Tohoku University32
已完成
不适用
The Visceral Adiposity Measurement and Observation StudyHIVHIV-InfectionsHIV-1-infectionHIV I InfectionHIV LipodystrophyHIV Infection PrimaryHIV-Associated LipodystrophyHIV Disease ProgressionLipohypertrophyLiver DiseasesNAFLDLiver FibrosisWaist CircumferenceBMIEctopic FatLiver FatHepatic SteatosisNASHHepatic FibrosisNCT05383456Theratechnologies196